Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The 40 most successful stoners of all time.
Maybe we should lighten up on managements lighting up.
http://marijuanastockreview.com/the-40-most-successful-stoners-of-all-time/
Link to older interview.
http://marijuanastockreview.com/indoor-harvest-inqd-interview-new-to-the-street/
Closes of Underwriters’ Over-allotment.
http://marijuanastockreview.com/eastside-distilling-esdi-inc-announces-closing-of-underwriters-over-allotment/
True Leaf Offering Circular
http://marijuanastockreview.com/true-leaf-offering-circular/
Revive Kombucha Raises $7.5 Million
“Our investment reflects our belief in the strength and promise..."
Eric Lauterbach, President, Consumer Division, Peet's Coffee
https://www.drinkpreneur.com/beverage-industry-news/markets/revive-kombucha-raises-7-5-million/
Break into Sales! DSD Representative with Growing Company.
The DSD Representative will work out of a company van and their own home office, based in the New York City area.
ESSENTIAL JOB FUNCTIONS:
Routinely sit in a vehicle for long periods of time.
Occasionally stand for long periods of time.
Walk for short periods of time.
https://newyork.craigslist.org/mnh/csr/d/break-into-sales-dsd/6258443054.html
CHO Platforms Unsustainable.
BioPharma Reporter.
CHO platforms unsustainable for biopharma's future, says Dyadic
By Dan Stanton+, 25-Aug-2017
Industry is feeling the low yield and high cost limitations of the CHO cell line and must look to alternatives to make next-generation biological products, says fungal-based protein expression firm Dyadic International.
http://www.biopharma-reporter.com/Upstream-Processing/CHO-cell-lines-unsustainable-for-biopharma-s-future-says-Dyadic
Dyadic Announces $5 Million Stock Repurchase Program.
JUPITER, Fla., Aug. 16, 2017 (GLOBE NEWSWIRE) — Dyadic International, Inc. (DYAI) (“Dyadic”) announced that its Board of Directors has authorized a new stock repurchase program, under which the Company may repurchase up to $5 million of its outstanding common stock.
Under this new stock repurchase program, Dyadic may repurchase shares in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The extent to which Dyadic repurchases its shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by Dyadic’s management. The repurchase program may be extended, suspended or discontinued at any time. The Company expects to finance the program from existing cash resources.
“We believe that Dyadic’s stock does not reflect Dyadic’s growth prospects and the value of our proprietary C1 technology,” said Michael Tarnok, Dyadic’s Chairman. He further stated that “this new stock repurchase program provides the Company with an opportunity to provide liquidity to shareholders and increase shareholder value.”
About Dyadic International, Inc.
Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical protein production system based on the fungus Myceliophthora thermophila, nicknamed C1. The C1 microorganism, which enables the development and large scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, production and performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines, monoclonal antibodies, biosimilars and/or biobetters, and other therapeutic proteins. Dyadic pursues research & development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in developing and manufacturing biopharmaceuticals which these technologies help produce. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers and, hopefully, improve access and cost to patients and the healthcare system, but most importantly save lives.
Please visit Dyadic’s website at www.dyadic.com for additional information, including details regarding Dyadic’s plans for its biopharmaceutical business.
Dyadic trades on the OTCQX tier of the OTC marketplace. Investors can find real-time quotes, market information and financial reports for Dyadic in the Company’s annual and quarterly reports which are filed with the OTC markets. Please visit the OTC markets website at www.otcmarkets.com/stock/DYAI/quote.
Safe Harbor Regarding Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks, uncertainties and other factors that could cause Dyadic’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Investors are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Any forward-looking statements speak only as of the date of this press release and, except as required by law, Dyadic expressly disclaims any intent or obligation to update or revise any forward-looking statements to reflect actual results, any changes in expectations or any change in events. Factors that could cause results to differ materially include, but are not limited to: (1) general economic, political and market conditions; (2) our ability to carry out and implement our biopharmaceutical research and business plans and strategic initiatives; (3) Dyadic’s ability to retain and attract employees, consultants, directors and advisors; (4) our ability to implement and successfully carry out Dyadic’s and third parties research and development efforts; (5) our ability to obtain new license and research agreements; (6) our ability to maintain our existing access to, and/or expand access to third party contract research organizations in order to carry out our research projects for ourselves and third parties; (7) competitive pressures and reliance on key customers and collaborators; and (8) other factors discussed in Dyadic’s publicly available filings, including information set forth under the caption “Risk Factors” in our December 31, 2016, Annual Report filed with OTC Markets on March 24, 2017. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us.
Contact:
Dyadic International, Inc.
Thomas L. Dubinski
Chief Financial Officer
Phone: 561-743-8333
Email: tdubinski@dyadic.com
Updated Report.
Updated report slash profile. Yes we're compensated, but that didn't slow New Age Beverages going from $0.31 to over $6 in under two years.
http://alternativeenergystockreview.ning.com/
Oh and past performance of other ideas/clients is, of course, no indication of how new ideas/clients will perform.
Forget Craft Beer. Craft Liquor Is the Next Big Thing.
https://seekingalpha.com/instablog/295897-roland-rick-perry/5025864-eastside-distilling-graduates-nasdaq-capital-markets
Coconut Water.
Just came across this old (2015) but great story again. That's the great thing about the beverage business, you just never know what may skate into New Age Beverages life tomorrow, next month or even a year from now - as well as with Eastside Distilling (ESDI) another acquisition minded play.
-----
Coconut Water Maker Vita Coco Broadens Overseas Footprint
A decade after being first delivered to New York bodegas on inline skates, it is now sold in about 30 countries, twice as many as a year ago, said Michael Kirban, co-founder and chief executive of closely held All Market Inc., which owns Vita Coco.
About 30% of revenue will be generated outside the U.S. this year, with the company on track to book another year of double-digit sales growth overall, he added in an interview. New markets since late 2014 include China, New Zealand and Spain, with South Africa planned for later this year.
Global retail sales of Vita Coco rose 31% last year to $421.1 million, surpassing PepsiCo Inc.'s (PEP) Kero Coco brand for the first time, according to Euromonitor. Long popular in countries like Brazil and India, coconut water remains a niche category in most of the world but is growing quickly.
Coca-Cola Co. (KO) veteran Mike Shepherd is overseeing the expansion in Asia Pacific, where Vita Coco is currently distributed in nine countries. He joined All Market in April after 15 years at the soft drink giant, most recently as general manager for Hong Kong, Taiwan and Mongolia.
Mr. Shepherd expects to have a regional team of 10 to 12 people in Hong Kong by the end of the year, in addition to existing offices in Japan, South Korea, the Philippines and Singapore.
New York-based All Market sold a roughly 25% stake to Beijing's Reignwood Group for about $165 million last year. Reignwood is the exclusive distributor of Red Bull energy drinks in China and is now slowly rolling out Vita Coco in the country.
Mr. Kirban said Vita Coco is now in about 15,000 stores in three Chinese cities and expects to expand distribution to 40,000 stores by this summer. The company launched a multimillion-dollar marketing campaign in the country earlier this year, including digital, magazine and billboards ads.
"If China keeps going like it's going, it could be 40% of the overall business in three to five years," said Mr. Kirban. So far, though, it is only about 3% of the company revenue.
The company says sales in Europe are up about 80% from last year. It says it now sells more Vita Coco in London than in New York.
In the U.S., where Vita Coco has an estimated 40% market share, sales are growing around 30% this year, according to the company. Mr. Kirban is overseeing daily operations in the U.S. after country president Jeff Popkin left the company earlier this month.
Vita Coco's main competitors in the U.S. are Coke, which owns the Zico coconut water brand, and PepsiCo, which owns O.N.E. and Naked. Dr Pepper Snapple Group Inc. (DPS) handles the bulk of Vita Coco's U.S. distribution.
Mr. Kirban said All Market has had conversations with potential buyers in recent years other than Reignwood about selling stakes in the business, but that there are no talks currently.
Mr. Kirban, co-founder Ira Liran and Belgian investment firm Verlinvest together own more than 50% of All Market. About 10% is owned by other shareholders, including employees.
Writer to Mike Esterl at mike.esterl@wsj.com
http://ih.advfn.com/p.php?pid=nmona&article=66610235
PepsiCo in bid to acquire Vita Coco owner:
(Reuters) - Soft drink maker PepsiCo Inc (PEP.N) is in talks to acquire All Market Inc, the owner of coconut water brand Vita Coco, whose celebrity investors include Madonna and Matthew McConaughey, people familiar with the matter said on Friday.
http://www.reuters.com/article/us-allmarket-m-a-pepsico-idUSKBN18M2JJ
Wow, Lam Ngoc Minh.
Starting from a family-owned factory, after 12 years, Lam Ngoc Minh Company has introduced Lien A Mattress Mfrs Company Ltd., which became a business that accounted for 98% of Vietnamese mattresses exported to the United States.
Translated to English.
http://www.doanhnhansaigon.vn/chan-dung-doanh-nhan/tgd-lien-a-ngoi-mot-cho-khong-the-thanh-toan-cau/1083907/
From the saddle
As the eldest son in the family of six brothers, Lam Ngoc Minh was entrusted by his father, Lam Ngoc Hiep, with great expectations when he directed his studies in chemistry at Ho Chi Minh City Polytechnical University and for his work. At the Pan-Asian production facility from the second year (1995).
At that time, during one visit, PU mattresses were imported from Thailand, Minh had the intention of applying this remarkable technology in mattress production in Vietnam. Then, Minh went to Malaysia to learn and learn about this technology.
At that time, when the motorcycle assembly movement in Vietnam flourished, he boldly suggested that his father shift production to Liaison. Using knowledge from the auditorium, research fellow, access to raw materials and invest in PU saddles.
Later on, Lien Asia became famous as the only unit in Vietnam to produce PU saddle products with durability and elasticity better than conventional saddles on the market. From that success, Liaoning was transformed from a family-owned factory into a private company and in 2000, the young man Lam Ngoc Minh was promoted to vice president of the company.
Although successful with the saddle, but in Minh always painful desire to continue the tradition of producing mattresses of the family. Not yet implemented, in 2002, the State issued a policy of limiting the assembly of motorcycles, a series of Liaison partners have to close. Due to the implementation of the policy for partners to restructure capital, so that time, Lien Asia faced difficulties when not able to return capital.
"I determined I could not stop because the machine was still there, but if it continues, the order is reduced and can not be used as the main product. Therefore, I decided to take Lien A back to the way of producing natural latex mattresses, "Minh recalled.
Coming to the mattress brand has great export value
Back to production of rubber mattresses, the question posed to Lam Ngoc Minh is how to make a difference? Along with studying and finding the formulation of mattress with the characteristics of deodorizing, high elasticity ... and active in mold, Minh said that the third secret to make a difference is to be active Distribution system. It was not easy because he disagreed with his father.
According to Lam Ngoc Hiep, it is advisable to use direct sales channels because distribution channels are expensive and difficult to manage. Meanwhile, Minh insists that through distribution channels Together, we will expand our market and step by step reach outward. In fact, it has proven that this is one of the key decisions that will help Lien Asia build and maintain its foothold in the market.
"The journey to build a product distribution channel is not easy either. Most agents do not know about the Pan-Asian mattress brand, so do not dare risk taking our goods. But in the difficulty again appeared wisdom ... ", Minh recalled.
The agents do not receive goods from Lien A, Minh moved through convincing Metro Cash & Carry Vietnam wholesale distribution of Lien Asia products. In 2002, accepted by Metro, the name was widely known from Asia and dealers began to accept distribution to Lien Asia.
In the domestic market, with the thought to understand and meet all requirements of customers, Liaison has strongly improved from brand identity, to product innovation. As a result, Liaison has created a mattress to lie on different levels of rubber in different areas of contact with the body lying. Lien Asia is also the first brand in Vietnam to allow customers to try the product before buying.
These changes are small, but they have received the satisfaction of most of their customers and helped Liaise keep their market share growing at 20-25% for many years. Only in 2013, while the market fell, Lien Asia maintained a 17% growth, with total revenue of nearly 239 billion, ensuring stable income for nearly 400 employees.
"Also in 2013, Lien A has invested in a third factory in Binh Duong Province (two former factories were built in 1991 and 2000, located in District 6 and District 12, Ho Chi Minh City) Mr. Minh proud to share.
In addition to the retail market, Lien Asia also attaches importance to quality and bring products into the hotel and resort projects. At present, Lien Asia products can meet the standard of mattress use of four star star or more as the mattress must be durable, odorless, meet fire protection standards ...
With such a move, Minh has brought the Asia-Pacific mattress from a lesser-known brand to become one of the more well-known names in mattress manufacturing and trading, alongside Kymdan and Van Thanh. .
Without stopping in the domestic market, Minh also brought Lien A to conquer overseas markets. Through learning, he knows that, with the international market, the most important factor is the quality, safety for the health of the user. Therefore, he bravely invested in modern machinery and technology and spent 15 billion VND to build research and development (R & D) department in Lien A.
In terms of quality, Lien A invites the quality assurance unit of Germany (the country with the world's most prestigious mattress quality standards) to verify and grant the LGA Certificate and Certification Only ECO safety for Lien A product.
Thanks to these steps, Lam Ngoc Minh gradually brought Lien Asia products to stable in 24 markets in the world, including big markets such as USA, Korea, Switzerland and Taiwan. Particularly in the US market, in 2012, Lien Asia has been certified as a business enterprise accounted for 98% of the mattress from Vietnam into the United States.
Can not sit down
Talking about his business secrets, he said: "My business principle is completely in the direction of self-research, research. Thanks to research, hard to observe, customer survey, I just know, want to business success must have diverse product lines and make a difference. Reduced hardness, reduced weight of the mattress, but the quality raised through the change of mattress formula is the result of this principle. "
In addition, to be successful, businesses must have their own culture. Therefore, Minh is very focused on developing teambuilding activities for all employees or staff of each area on Saturday every week. "This is an activity that connects employees, helps me understand more about employees, and helps employees understand, capture and share my vision in business," he explained.
Mr. Minh's voice became vibrant when sharing his aspirations for the future. His father's message was that Liaise be the world leader in mattresses. In order to realize this goal, he needed time and manpower strong enough. In the immediate future, he is recruiting and inviting staff from multinational companies to work in Liaison.
"Determining 'can not sit down to become a global company', I am promoting the US to open the company, directly clashing with American culture and skills. If successful, this will be the framework for Liaoning to develop in other markets in the world, "said Minh.
Chat with businessman Lam Ngoc Minh
* Technically trained, but must do business, to him what is the biggest challenge?
- When getting into business, I have to spend time getting more stuff. Logic skills, thinking is the strength, but other skills such as negotiation, management ... is the weakness of the technical people.
* He once shared, business people must be flexible to achieve good results?
- Yes! Enthusiastic creativity, but creators also need to remember that the product is marketed to fit the needs of consumers to have the opportunity to stand firm, not just satisfy themselves.
Selling prices must be reasonable, high or lower than the general level of the market also create bad effects.
> Boss Lac Vietnam: Business is not just for the money >
Entrepreneurs must be good at division
>Miti boss: Leave hospital bag sewing >
Vinamilk's new masterpiece
BAO GIANG / Investment Newspaper
Bottled water top beverage based on volume sales.
After years of speculation, bottled water officially is the No. 1 beverage based on volume in the United States. Earlier this year, New York-based Beverage Marketing Corporation (BMC) announced that bottled water overtook carbonated soft drinks for the top spot on a volume basis.
http://www.bevindustry.com/articles/90348-state-of-the-industry-bottled-water-top-beverage-based-on-volume-sales
CHO stopper? Biogen looks to alternative cell lines for future of bioproduction
By Dan Stanton+, 28-Apr-2017
The Chinese hamster ovary (CHO) cell line is not the future for biomanufacturing says Biogen, which will publish results from a study of alternative hosts later this year.
http://www.biopharma-reporter.com/Bio-Developments/Biogen-working-on-a-radical-departure-from-the-CHO-platform
From China to the Culture Dish: A Brief History of the CHO cell line
By Gareth MacDonald+, 07-Aug-2013
Scientists say the Chinese hamster genome published last month will help biomanufacturers develop better CHO cell lines.
http://www.biopharma-reporter.com/Bio-Developments/From-China-to-the-Culture-Dish-A-Brief-History-of-the-CHO-cell-line
(In 1987, Genentech's plasminogen activator Activase becomes the first human therapeutic produced using CHO cells. The firm still makes the drug for patients who have suffered heart attacks and acute massive pulmonary embolism.)
Competition.
Excerpt from May conference call. Of course listen to/read safe harbor statements preceding all CC's.
Unidentified Analyst
Okay, Mark, can you discuss the competition out there and with regard to that, what kind of patent protection do you have? Maybe discuss the strongest patents that you think you have and what kind of expiration dates these patents have? I mean, you have been doing this for a while, and ultimately someone, Dyadic or somebody else is going to want to – if this is successful proof of concept, is going to want to take this to the next step and start trials and go to the FDA and all that stuff takes a lot of time. So I’m just wondering what kind of patent protection you have and what kind of competitions is out there?
Mark Emalfarb
Yes, the competition, let’s address it first. A lot of competition in bacteria, yeast, CHO cells, so different levels of competition. Certain cell lines like bacteria can’t make glycoproteins at least naturally, so there is a variety of other expression systems out there. We did believe that C1 has the attributes and the properties that puts it to the top of the class and gives people the confidence that with the synthetic biology and the genomics and OMICS or the other tools that are out there today and getting better, quicker, faster and cheaper, it can be applied as cell line, that’s been proven industrially to be productive, robust and versatile and scalable, and this is the cell line you want to work with to get to the future.
(Cho cells from Chinese Hamster Ovaries are used in some of the best selling monoclonal antibodies such as Rituxan, Humira and Enbrel)
Lucky Post #7.
Just had to grad that poll position. Studying.
Pete, your everywhere.
C-1 = Air Force One ?
Alkaline Water Co. Achieves Another Record Month with $1.84 Million in Sales.
Last three months have been highest sales in Company's history
SCOTTSDALE, AZ--(Marketwired - Jun 8, 2017) - The Alkaline Water Company Inc. (OTCQB: WTER), with products bottled under the trademark Alkaline88®, (the "Company") is proud to announce that in May 2017 the company sold a record $1.84 million of Alkaline88® water to our customers.
The Company is the creator of an innovative, state-of-the-art, proprietary electrolysis beverage process. The Company packages and sells its alkaline water in 1-gallon, 3-liter, 1-liter, 700ml and 500ml sizes to over 31,000 retail locations in all 50 states.
"We are off to a great start to our 2018 fiscal year. Our first quarter sales should exceed any quarter in the Company's history. Our May 2017 sales of $1.84 million are up over 80% from May 2016," states Richard A. Wright, CEO and President of The Alkaline Water Company Inc. "The recent additions to our sales team, production facility expansion and national rollout have translated into increased revenue and market share. The Company has a very experienced and dedicated group of employees that are making this growth possible. We look forward with great anticipation to continued market success and increased shareholder value over the rest of this fiscal year," concludes Mr. Wright.
The Alkaline Water Company Inc. (OTCQB: WTER) has developed an innovative, state-of-the-art, proprietary electrolysis process that produces healthy alkaline water for a balanced lifestyle. The Company is focused on the business of distributing and marketing for retail sale of its cost-effectively packaged Alkaline88® water beverage products. Visit: www.thealkalinewaterco.com.
http://www.otcmarkets.com/stock/WTER/news/Alkaline-Water-Co--Achieves-Another-Record-Month-with--1-84-Million-in-Sales?id=161471&b=y
First Quarter FY 2018 Revenue Projected to Exceed $5 Million.
"Further confirmation of our increasing success and our growth in production facilities has contributed to our first-quarter projected gross sales of $5 million. We are expecting similar quarter-over-quarter growth throughout the remainder of the year, and our projections currently target a $24 million revenue goal for fiscal 2018."
http://www.otcmarkets.com/stock/WTER/news/Alkaline-Water-Co--Reports-Record-Fiscal-2017-Financial-Results-and-Forecasts-First-Quarter-Sales?id=164804&b=y
Fiscal 2017 Sales Top $12.7 Million, Up 80 Percent.
Revenue for the year ended March 31, 2017, was $12,763,630, as compared to $7,088,806 for the same period ended March 31, 2016, an increase of 80 percent. The increase in revenue is due to the continued acceptance of product by consumers and the successful expansion into additional retailers.
http://www.otcmarkets.com/stock/WTER/news/Alkaline-Water-Co--Reports-Record-Fiscal-2017-Financial-Results-and-Forecasts-First-Quarter-Sales?id=164804&b=y
Whoah.
Not much to read about here. And they're public why?
Pledge Petro.
I don't get why there are running two sites? Causes confusion and they could just redirect the URL to Propel. It's not like they don't have the money.
http://www.pledgepcorp.com/stock-data/analyst-coverage
And why does the Propell site have zero references to being a publicly traded company? Not even press releases.
http://propell.com/company/
I know they are interested in communicating with investors, otherwise, they wouldn't have presented at the SeeThru Conference, where I first heard of them.
This is just a 'fun' investment, but they can make a little effort and make it more fun.
Recent News.
Best Archive at Marketwired.
http://www.marketwired.com/AdvancedSearch/AdvancedSearchResults.aspx?sid=a311253f-a091-41ee-99c2-128505830d21
Older PPT (1/16).
http://content.equisolve.net/propell/media/79ca4b57c1c78ca331dfe8a54ab39a20.pdf
Jack Welch.
I put this up on SA because it's contrary to logic, to imply or infer that an enthusiastic CEO is doing something inherently wrong.
To paraphrase Jack Welch.
"I don't think my stock can ever get overvalued. Let me explain why. My whole modus operandi, my whole business approach is to hire the best managers and train them to make sure that I have the best managers in all of business. And that means if my stock gets above what I think is fair value, I will use that currency to buy a company with lesser skills at the management level and install my managers thereby increasing the value of General Electric. That's my business plan. It's worked for me for 20 years.."
I've worked with CEO's who trumpet their progress and I've worked with CEO's who believe if they just put their nose to the grindstone, the share price will take care of itself.
The approach the CEO takes (with exceptions of course) is one of the leading indicators as to whether a company may in the future, trade at a premium valuation, or trade at a discount to market or its peers.
There's nothing inherently evil about having an overvalued stock price - using whatever metric one uses, to make such a declaration.
Global Shipping Fleet Braces for Chaos of $60 Billion Fuel Shock.
Interesting article from Bloomberg
Global Shipping Fleet Braces for Chaos of $60 Billion Fuel Shock.
“There will be an absolute chaos,” said Lars Robert Pedersen, the deputy secretary general of Denmark-based BIMCO. “We are talking about 2.5 million to 4 million barrels a day of fuel oil to basically shift into a different product.”
http://alternativeenergystockreview.ning.com/profiles/blogs/global-shipping-fleet-braces-for-chaos-of-60-billion-fuel-shock
Genoil Hydroconversion Unit Economics Show Fast ROI for Existing Bunker Port Installations
http://www.nasdaq.com/g00/press-release/genoil-hydroconversion-unit-economics-show-fast-roi-for-existing-bunker-port-installations-20170516-00409?
Alternative Energy Stock Review
http://alternativeenergystockreview.ning.com/
Reverse Splits.
Understandably reverse splits create a feeling of hurt and a dampening of enthusiasm for early (pre-reverse) investors.
However one has to block out the past and look at "an" opportunity, as if today, is the first day one discovered the opportunity.
In basic terms, in any stock, it doesn't matter if you're down 50% or up 50% in the particular investment.
What matters is your personal assessment of the future potential, as if today was the first day you discovered it.
Assess and then decide. Forget the past.
Marcum Presentation.
Like OMG. One gadfly.
Marcum Presentation.
Part art, part science, 100% perfect. Attended 16 presentations and this was among the best. Second only to the Takung Art (TKAT) presentation.
The room was well attended, with 6 concurrent competing presentations.
Marcum Presentation.
Great presentation, the room was full. Not sure Marcum webcasts, but being video experts - Adam Mutchler was taping it.
Maneuvering For An Uplisting?
PORTLAND, OR / ACCESSWIRE / June 12, 2017 / Eastside Distilling, Inc. (ESDI) ("Eastside" or the "Company"), a producer of award-winning master-crafted spirits, announced today that its Board of Directors have approved a 1-for-3 reverse split of the Company's outstanding common stock from 9,939,649 to 3,313,217, and a proportional decrease in the Company's authorized common stock from 45 million shares to 15 million shares. Pursuant to the Nevada Revised Statutes, the Company's Board of Directors is authorized to effectuate a reverse stock split without stockholder approval where such split is accomplished with a concurrent proportional decrease in the Company's authorized common stock.
Steve Shum, CFO of Eastside, said, "Our goal is for Eastside to uplist to a major national exchange or market and gain access to a greater number of investors that invest in companies that are nationally listed. The reverse split is being done so that the Company can meet the share price limitations it must meet to list on a national exchange such as NASDAQ or NYSE. Listing is subject to our satisfying the full listing requirements, of which share price is a primary one. These price and trading rules apply somewhat onerous burdens on small companies like us. Despite that, we see uplisting as having big advantages to our stockholders that outweigh the short term inconveniences associated with conducting a reverse split. Any stockholders who would have questions about the reverse split, are welcome to contact Grover, our Chairman, or myself for a further explanation."
Full release: https://finance.yahoo.com/news/eastside-distilling-announces-plan-effect-214600748.html
Three-quarters of Brits admit to bedtime snacking.
Three quarters of Brits admit to bedtime snacking - and it might be costing them a good night's sleep
Most popular evening appetisers include chocolate, crisps, biscuits and buttered toast.
Millions of Brits admit to binging at bedtime – to stave off late-night hunger pangs.
A new study of 2,000 people shows three quarters will eat just before bedtime, with 58 per cent reaching for naughty treats that may hinder sleep rather than healthy snacks that can help.
Most popular evening appetisers include chocolate, crisps, biscuits and buttered toast.
But while many people feel hungry before bedtime, a fifth believe their choice of food may be leading to a bad night’s sleep and experts have confirmed our choice of midnight feasts may end up COSTING us a good night’s kip, while opting for the right foods, such as cherries, can help you get a better night’s sleep.
http://www.mirror.co.uk/news/uk-news/three-quarters-brits-admit-bedtime-10569174
MoneyOnMobile Marcum Microcap Conference.
DALLAS, June 6, 2017 /PRNewswire/ -- MoneyOnMobile, Inc. (MOMT), one of India's largest mobile phone-based payments network, announced today it will be presenting at the 2017 Marcum MicroCap Conference on June 15, 2017, at 11 a.m EDT. The conference will be held June 15-16 at the Grand Hyatt Hotel in New York City.
Watch the presentation live from your computer, tablet, or phone by following the link: http://wsw.com/webcast/marcum5/momt
"With our outstanding market position in India having served almost 200 million unique customers based on phone numbers, and a footprint of over 330,000 retailers MoneyOnMobile is excited to present to and network with the caliber of industry participants and investors who only Marcum Microcap can bring together in one place and time." said Harold Montgomery, Chairman and CEO of MoneyOnMobile, Inc.
The Marcum MicroCap Conference is a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2,000 investors and other participants from every segment of the microcap marketplace attend each year, including venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, and buy- and sell-side analysts, as well as senior executive teams from presenting companies and service providers to the microcap marketplace. The conference is presented by Marcum LLP.
Cowen target $15.
Cowen initiates coverage on Immunomedics (NASDAQ: IMMU) with a Outperform rating and a price target of $15.00.
Analyst Dr. Phil Nadeau comments "Immunomedics' lead candidate IMMU-132 has produced compelling Ph. II data in
the treatment of relapsed/refractory mTNBC and our physician consultants expect IMMU-132 to become part of the standard of care. We project a FY2019 launch, and that IMMU-132 will achieve $720MM in worldwide revenue in mTNBC by 2025."
FY 2017 EPS estimate is for a loss of $1.10 and FY 2018 EPS estimate is for a loss of $0.70.
For an analyst ratings summary and ratings history on Immunomedics click here. For more ratings news on Immunomedics click here.
Shares of Immunomedics closed at $7.47 yesterday.
$829,000 1Q.
They did $829,000 in the last quarter, that's a pretty impressive bar bill!
3 months ending March 31st, 2017.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12065052
Who's the expert on this?
So much conflicting information.
Any links, anyone?
Silverwood Partners.
Interesting link. Silverwood participated in 2009 and 2013 ($6 million - see form D) for Maverick https://fintel.io/if/maverick-brands and additionally, Silverwood participated in:
$18 million for Essentia http://silverwoodpartners.com/transactions/consumer-transactions/essentia-water-announces-venture-financing
$6 million for Kevita (later acquired by PEP)
http://silverwoodpartners.com/transactions/consumer-transactions/kevita-closes-series-d-financing-round-silverwood-partners-exclusive-financial-advisor
Also involved in Squincher
https://en.wikipedia.org/wiki/Sqwincher
http://sqwincher.com/
And Neuro
https://www.bevnet.com/news/2014/in-and-out-all-quiet-like-tsg-silently-exits-its-neuro-investment/
http://www.drinkneuro.com/
Curious.
Anybody know who the 'major' North American convenience store operator with 3,000 stores is, and the 'major' industry competitor that NBEV's store branded RTD tea is displacing?
(mentioned in the Maxim report)
Just curious. And I wonder how many of these CSO's have store branded teas. Seems like fertile ground.
#25 United Pacific 350
#26 Mapco Express 348
#27 Stewart's Shops Corp. 335
#28 Allsup's Convenience Stores Inc. 320
#29 Alon Brands Inc. 307
#30 Maverik Inc. 300
#31 E-Z Mart Inc. 283
#32 Anabi Oil 275
#33 Global Partners LP 251
Full List: http://www.cspdailynews.com/industry-news-analysis/top-convenience-stores-2017
This would be quite the Oh Thank Heaven!
http://corp.7-eleven.com/news/06-25-2015-7-eleven-sets-private-brand-bar-higher
MoneyOnMobile Withdraws Proposed Secondary Offering to Protect Shareholder Interests.
PR Newswire
DALLAS and MUMBAI, India, May 8, 2017
DALLAS and MUMBAI, India, May 8, 2017 /PRNewswire/ -- MoneyOnMobile, Inc. (OTCQX: MOMT) announced today that due to current market conditions, it has requested withdrawal of its recently filed S-1 registration statement and planned secondary offering, because it does not plan to proceed with the offering of securities contemplated by the Registration Statement. The Registration Statement has never been declared effective by the Securities and Exchange Commission, and no securities have been sold pursuant to the Registration Statement.
"Enhancing shareholder value is our number one priority. Current market conditions are such that proceeding with a registered offering is not in the best interest of our shareholders," said Harold Montgomery, MoneyOnMobile CEO and Chairman. "We have successfully raised more than $45mm in equity and debt securities privately over the past few years. We have also added non-dilutive capital through lines of credit in India to drive growth."
About MoneyOnMobile, Inc.
MoneyOnMobile, Inc. is a global mobile payments technology and processing company offering mobile payment services through its Indian subsidiary. MoneyOnMobile enables Indian consumers to use mobile phones to pay for goods and services or transfer funds from one cell phone to another. It can be used as simple SMS text functionality or through the MoneyOnMobile application or internet site. MoneyOnMobile has more than 325,000 retail locations throughout India.
Safe Harbor Statement
This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. This release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K filed on August 19, 2016. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.
Web site: www.MoneyOnMobile.in
Twitter: https://twitter.com/MoneyOnMobile
Facebook: https://www.facebook.com/MoneyOnMobile
LinkedIn: https://www.linkedin.com/company/MoneyOnMobile
YouTube: https://www.youtube.com/channel/UCxqO4N1z9acnQmEysjqfBaQ
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/moneyonmobile-withdraws-proposed-secondary-offering-to-protect-shareholder-interests-300452886.html
SOURCE MoneyOnMobile